Back to Search
ANDREW MILLER, M.D.
M.D.
Psychiatry Physician
NPI: 1538327283Individual
Specialties, Licenses & Credentials
Psychiatry & Neurology — Neurology with Special Qualifications in Child Neurology
Code: 2084N0402X
01069766A(IN)
Clinical Trials (4)
4
Linked Trials
0
Recruiting
4
With Results
A Study of Infliximab for Treatment Resistant Major Depression
NCT00463580COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
NCT04352101COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
NCT02796755COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
NCT00352885COMPLETEDPHASE4STUDY_CHAIR
Research & Publications (20)
Antidepressants for the treatment of depression in people with cancer.
PMID 36999619·Cochrane Database Syst Rev·2023
6-review
Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.
PMID 25529904·Brain Behav Immun·2015
2-rct
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.
PMID 23624296·Brain Behav Immun·2013
2-rct
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
PMID 23575741·Neuropsychopharmacology·2013
2-rct
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
PMID 22945416·JAMA Psychiatry·2013
4-observational
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
PMID 22353759·Neuropsychopharmacology·2012
4-observational
Translation towards personalized medicine in Multiple Sclerosis.
PMID 18789804·J Neurol Sci·2008
6-review
Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect.
PMID 17433820·J Neurol Sci·2007
6-review
Health-related quality of life in multiple sclerosis: The impact of disability, gender and employment status.
PMID 16468081·Qual Life Res·2006
8-other
Pseudobulbar affect in multiple sclerosis: toward the development of innovative therapeutic strategies.
PMID 16674978·J Neurol Sci·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 550 CONGRESSIONAL BLVD STE 115
CARMEL, IN 46032 - Phone
- (833) 351-8255
Quick Facts
- NPI
- 1538327283
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile